Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus.

BACKGROUND Endoscopic ablation of Barrett's esophagus has been described in which various thermocoagulation modalities are used in combination with a high dose of a proton pump inhibitor. No randomized comparison of ablation strategies has been published. METHODS Referred patients were screened to identify those with Barrett's esophagus 2 to 7 cm in length, without high-grade dysplasia or cancer. Included patients received pantoprazole (40 mg twice a day), followed by randomization to treatment with argon plasma coagulation (APC) or multipolar electrocoagulation (MPEC). The primary outcome measure was the number of treatment sessions required for endoscopic ablation. RESULTS Of 235 patients screened, 52 were randomized. The mean length of Barrett's esophagus was 3.1 cm in the MPEC group vs. 4.0 cm in the APC group (p = 0.03). Otherwise, the treatment groups were similar with regard to baseline characteristics. The mean number of treatment sessions required for endoscopic ablation was 2.9 for MPEC vs. 3.8 for APC (p = 0.04) in an intention-to-treat analysis (p = 0.249, after adjustment for the difference in length of Barrett's esophagus). The proportion of patients in which ablation was endoscopically achieved proximal to the gastroesophageal junction was 88% for the MPEC group vs. 81% for the APC group (p = 0.68) and histologically achieved in 81% for MPEC vs. 65% for APC (p = 0.21). The mean time required for the first treatment session was 6 minutes with MPEC vs. 10 minutes with APC (p = 0.01) in per protocol analysis. There was no serious adverse event, but transient moderate to severe upper-GI symptoms occurred after MPEC in 8% vs. 13% after APC (p = 0.64). Conclusions Although there were no statistically significant differences, ablation of Barrett's esophagus with pantoprazole and MPEC required numerically fewer treatment sessions, and endoscopic and histologic ablation was achieved in a greater proportion of patients compared with treatment with pantoprazole and APC.

[1]  G. Eisen Ablation therapy for Barrett's esophagus. , 2003, Gastrointestinal endoscopy.

[2]  Masoud Panjehpour,et al.  Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. , 2003, Gastrointestinal endoscopy.

[3]  W. Samowitz,et al.  Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. , 1993, Gastroenterology.

[4]  Patricia L. Blount,et al.  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. , 1993, Gastroenterology.

[5]  M. Vieth,et al.  Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. , 2000, Gastrointestinal endoscopy.

[6]  The adoption of ablation therapy for Barrett's esophagus: A cohort study of gastroenterologists , 2002 .

[7]  N. Shepherd,et al.  Photothermal laser ablation of Barrett’s oesophagus: endoscopic and histological evidence of squamous re-epithelialisation , 1997, Gut.

[8]  J. Devière,et al.  Long-term Follow-Up and Factors Predictive of Recurrence in Barrett's Esophagus Treated by Argon Plasma Coagulation and Acid Suppression , 2002, Endoscopy.

[9]  J. Devière,et al.  Eradication of Barrett’s mucosa with argon plasma coagulation and acid suppression: immediate and mid term results , 1998, Gut.

[10]  M. Morino,et al.  Endoscopic ablation of Barrett's esophagus using argon plasma coagulation (APC) following surgical laparoscopic fundoplication , 2003, Surgical Endoscopy And Other Interventional Techniques.

[11]  J. Dent,et al.  Healing and relapse of severe peptic esophagitis after treatment with omeprazole. , 1988, Gastroenterology.

[12]  A. Ippoliti,et al.  Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study , 1999, Gut.

[13]  A. Bhattacharyya,et al.  Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[14]  Y. K. Chen,et al.  Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. , 1999, Gastrointestinal endoscopy.

[15]  R. Sampliner,et al.  Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor , 2000, Alimentary pharmacology & therapeutics.

[16]  N. Brandalise,et al.  Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[17]  J. Byrne,et al.  Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. , 1998 .

[18]  F. Ramirez,et al.  The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[19]  J. de Caestecker,et al.  Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus: factors determining persistence and recurrence of Barrett’s epithelium , 2002, Gut.

[20]  D. Faigel,et al.  Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. , 2001, Gastrointestinal endoscopy.

[21]  J. Riemann,et al.  [Barrett esophagus with severe dysplasia in argon beam therapy]. , 1998, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.

[22]  R. Sáenz,et al.  Ablation with argon plasma coagulator (APC) for Barrett's esophagus. , 2001 .

[23]  J. Byrne,et al.  Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation , 2001, The British journal of surgery.

[24]  T. Sauerbruch,et al.  Treatment of Barrett's esophagus by endoscopic argon plasma coagulation. , 1997, Endoscopy.

[25]  R. Sampliner,et al.  Impact of esophageal acid exposure on the endoscopic reversal of Barrett’s esophagus , 2000 .

[26]  R. Sampliner,et al.  Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. , 1996, Gastrointestinal endoscopy.

[27]  P. Devitt,et al.  Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery. , 2004, Gastrointestinal endoscopy.

[28]  M. Scheurlen,et al.  Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: a prospective study. , 1998, Scandinavian journal of gastroenterology.